# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.05 per share. This is a 155.56 percent increase over losses of $...
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(...
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(...